Avner Ingerman
Plus aucun poste en cours
Profil
Avner Ingerman worked as Director of Research & Development at Johnson & Johnson Medical Israel, Vice President of Ophthalmology at Regeneron Pharmaceuticals, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Chief Clinical Officer at Ohr Pharmaceutical, and Chief Development Officer at Gemini Therapeutics.
He holds a doctorate degree from Sackler School of Medicine.
Anciens postes connus de Avner Ingerman
| Sociétés | Poste | Fin |
|---|---|---|
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2017 |
| GEMI THER | Corporate Officer/Principal | - |
| ACHILLION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Johnson & Johnson Medical Israel
 Johnson & Johnson Medical Israel Medical DistributorsDistribution Services Johnson & Johnson Medical Israel markets and supports medical devices. The private company is based in Israel. | Chief Tech/Sci/R&D Officer | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Avner Ingerman
| Sackler School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
Johnson & Johnson Medical Israel
Johnson & Johnson Medical Israel Medical DistributorsDistribution Services Johnson & Johnson Medical Israel markets and supports medical devices. The private company is based in Israel. | Distribution Services |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
